Clinical Trial Update: HRD Status Reference Standard Based on WGS

View source ↗

Summary

This clinical trial completed evaluation of an HRD status reference standard based on whole-genome sequencing for ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Lei Li | Conditions: Ovarian Cancer | Status: COMPLETED